Categories AlphaGraphs, Earnings, Health Care
Key highlights from Merck’s (MRK) Q3 2025 earnings results
Merck & Co., Inc. (NYSE: MRK) reported its third quarter 2025 earnings results today.
Total worldwide sales of $17.3 billion were up 4% from the same period a year ago. Excluding the impact of foreign exchange, sales grew 3%.
GAAP net income increased 83% to $5.8 billion and EPS increased 87% to $2.32 compared to last year. Adjusted EPS rose 64% to $2.58.
For full-year 2025, the company now expects worldwide sales to be between $64.5-65.0 billion. Adjusted EPS is expected to be $8.93-8.98.
Prior performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
GS Earnings: A snapshot of Goldman Sachs’ Q4 2025 results
Banking giant Goldman Sachs Group, Inc. (NYSE: GS) on Thursday reported lower revenues and higher earnings for the fourth quarter of fiscal 2025. Net revenues decreased to $13.45 billion in
Morgan Stanley (MS) Q4 2025 Earnings: Revenue and profits beat estimates
Morgan Stanley (NYSE: MS) reported its fourth quarter 2025 earnings results today. Net revenues increased 10% year-over-year to $17.9 billion. Net income applicable to common shareholders was $4.3 billion, or
Key highlights from BlackRock’s (BLK) Q4 2025 earnings results
BlackRock, Inc. (NYSE: BLK) reported its fourth quarter 2025 earnings results today. Revenue increased 23% year-over-year to $7 billion. Net income decreased 33% to $1.13 billion, or $7.16 per share,
